Daniel Meron > Latham & Watkins LLP > Washington DC, United States > Lawyer Profile

Latham & Watkins LLP
555 ELEVENTH STREET, NW, SUITE 1000
WASHINGTON DC 20004-1304
DISTRICT OF COLUMBIA
United States
Daniel Meron photo

Work Department

Daniel Meron is global Co-chair of Latham & Watkins’ Healthcare & Life Sciences Practice, as well as Co-chair of the firm’s Healthcare Services & Providers Industry Group. He is in the Litigation & Trial Department of the firm’s Washington, D.C. office, a member of the Supreme Court & Appellate Practice and a member of the firm's Ethics Committee.

Mr. Meron has deep regulatory, investigatory and litigation experience across a broad range of healthcare and life sciences matters, from product approval, exclusivity determinations and promotional regulation by the US Food and Drug Administration (FDA) to coverage and reimbursement regulation by the Centers for Medicare & Medicaid Services (CMS), including fraud and abuse and white collar enforcement investigations and litigation.

Position

Litigation Partner

Career

http://www.lw.com/people/daniel-meron

Lawyer Rankings

United States > Healthcare > Health insurers

Latham & Watkins LLP‘s team combines a strong transactional practice with a focus on complex litigation. John Manthei and Ben Haas co-head the healthcare team from the Washington DC office, while fellow co-head Judith Hasko takes the lead from her base in San Francisco. On the litigation side, Gwyn Williams and David Tolley, both located in Boston, defend major insurers in a series of underpayment claims cases, while Washington DC’s Daniel Meron focuses on False Claims Act matters. Its transactional offering was further strengthened in October 2022 with the arrival of co-chair Jason Caron and Kevin Miller, both formerly at McDermott Will & Emery LLP. Based in Washington DC, Caron leverages clinical and government experience to advise clients on complex healthcare regulatory, reimbursement, and policy matters, while Chicago-based Miller’s practice focuses on advising private equity sponsors and portfolio companies on investment-related transactional healthcare insurance matters.